Investing News NetworkDecember 19, 2024Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trialDownload the PDF here.
Investing News Network29 August 2025 Appendix 4E and Preliminary Final Report Radiopharm Theranostics (RAD:AU) has announced Appendix 4E and Preliminary Final ReportDownload the PDF here. Keep Reading...
Investing News Network29 July 2025 Quarterly Activities/Appendix 4C Cash Flow Report Radiopharm Theranostics (RAD:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
Investing News Network27 July 2025 RAD receives IND approval from US FDA for Betabart (RV-01) Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)Download the PDF here. Keep Reading...
Investing News Network10 June 2025 RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases ImagingDownload the PDF here. Keep Reading...
Investing News Network03 June 2025 RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202Download the PDF here. Keep Reading...
African Discovery Group announces signing of Definitive Sales and Purchase Agreement for Butembo Copper Asset in the Democratic Republic of Congo; name change to Copper Intelligence, Inc 06 February
base-metals-investing African Discovery Group announces signing of Definitive Sales and Purchase Agreement for Butembo Copper Asset in the Democratic Republic of Congo; name change to Copper Intelligence, Inc 06 February